BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1782347)

  • 1. The catalytic effect of bovine serum albumin on the ortho rearrangement of the potential ultimate carcinogen, N-(sulfooxy)-2-(acetylamino)fluorene, generated enzymatically from N-hydroxy-2-(acetylamino)fluorene and evidence for substrate specificity of the enzymatic sulfonation of arylhydroxamic acids.
    Kolanczyk RC; Rutks IR; Gutmann HR
    Chem Res Toxicol; 1991; 4(2):187-94. PubMed ID: 1782347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bovine serum albumin on the extent of ortho rearrangement of N-(sulfooxy)-2-fluorenylacetamide and of enzymatically activated N-hydroxy-2-fluorenylacetamide and on the binding of reactive esters to nucleic acids.
    Kolanczyk RC; Gutmann HR; Rutks IR
    Chem Res Toxicol; 1992; 5(2):274-9. PubMed ID: 1643258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic effect of serum albumin on the o-rearrangement of N-sulfooxy-2-acetylaminofluorene, a potential hepatocarcinogen in the rat, to nonmutagenic sulfuric acid esters of o-amidofluorenols.
    Smith BA; Gutmann HR; Springfield JR
    Biochem Pharmacol; 1989 Nov; 38(22):3987-94. PubMed ID: 2597180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the synthetic ultimate carcinogens, N-sulfonoxy- and N-acetoxy-2-acetylaminofluorene, and of enzymatically activated N-hydroxy-2-acetylaminofluorene with nucleophiles.
    Smith BA; Springfield JR; Gutmann HR
    Carcinogenesis; 1986 Mar; 7(3):405-11. PubMed ID: 3512117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice.
    Lai CC; Miller JA; Miller EC; Liem A
    Carcinogenesis; 1985 Jul; 6(7):1037-45. PubMed ID: 3860305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solvolysis and metabolic degradation, by rat liver, of the ultimate carcinogen, N-sulfonoxy-2-acetylaminofluorene.
    Smith BA; Springfield JR; Gutmann HR
    Mol Pharmacol; 1987 Apr; 31(4):438-45. PubMed ID: 3574289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts.
    Lai CC; Miller EC; Miller JA; Liem A
    Carcinogenesis; 1987 Mar; 8(3):471-8. PubMed ID: 3815742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutagenicity and interactions of 2- and 4-(acetylamino)fluorene with cytochrome P450 and the aromatic hydrocarbon receptor may explain the difference in their carcinogenic potency.
    Ioannides C; Cheung YL; Wilson J; Lewis DF; Gray TJ
    Chem Res Toxicol; 1993; 6(4):535-41. PubMed ID: 8397005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ
    Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation.
    Allaben WT; Weeks CE; Weis CC; Burger GT; King CM
    Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
    Flammang TJ; Kadlubar FF
    Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of nucleophiles with the enzymatically-activated carcinogen, N-hydroxy-2-acetylaminofluorene, and with the model ester, N-acetoxy-2-acetylaminofluorene.
    Smith BA; Gutmann HR; Springfield JR
    Carcinogenesis; 1985 Feb; 6(2):271-7. PubMed ID: 3971491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of carcinogenic arylhydroxamic acids by human tissues.
    King CM; Olive CW; Cardona RA
    J Natl Cancer Inst; 1975 Aug; 55(2):285-7. PubMed ID: 1159819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent binding of N-hydroxy-N-acetyl-2-aminofluorene and N-hydroxy-N-glycolyl-2-aminofluorene to rat hepatocyte DNA: in vitro and cell-suspension studies.
    Corbett MD; Lim LO; Corbett BR; Johnston JJ; Wiebkin P
    Chem Res Toxicol; 1988; 1(1):41-6. PubMed ID: 2979710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
    Yost Y; Gutmann HR; Rydell RE
    Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductase activity of aldehyde oxidase toward the carcinogen N-hydroxy-2-acetylaminofluorene and the related hydroxamic acids.
    Kitamura S; Sugihara K; Tatsumi K
    Biochem Mol Biol Int; 1994 Dec; 34(6):1197-203. PubMed ID: 7696992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-hydroxy-2-acetylaminofluorene as effective inhibitor of aldehyde oxidase.
    Tatsumi K; Kitamura S
    Biochem Biophys Res Commun; 1986 Jul; 138(1):312-7. PubMed ID: 3741414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity of 1-hydroxy-3-methylcholanthrene and its electrophilic sulfate ester 1-sulfooxy-3-methylcholanthrene in Sprague-Dawley rats.
    Flesher JW; Horn J; Lehner AF
    Biochem Biophys Res Commun; 1998 Feb; 243(1):30-5. PubMed ID: 9473474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction products of the carcinogen N-hydroxy-4-acetylamino-4'-fluorobiphenyl with DNA in liver and kidney of the rat.
    Kriek E; Hengeveld GM
    Chem Biol Interact; 1978 Jun; 21(2-3):179-201. PubMed ID: 679396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of arylhydroxamic acids by N-O-acyltransferase of rat mammary gland.
    King CM; Traub NR; Lortz ZM; Thissen MR
    Cancer Res; 1979 Sep; 39(9):3369-72. PubMed ID: 476668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.